Kawasaki, Japan

Kasumi Ito

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Chiba University, Nof Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kasumi Ito. Retrieved from https://idiyas.com/inventor/kasumi-ito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kasumi Ito in Nucleic Acid Delivery

Introduction

Kasumi Ito is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of cationic lipids for nucleic acid delivery. Her innovative work focuses on improving intracellular dynamics for effective gene therapy applications.

Latest Patents

Kasumi Ito holds a patent for a cationic lipid that features a disulfide bond. This invention includes a lipid membrane structure, a nucleic acid introduction agent, and a pharmaceutical composition. The patent outlines methods for introducing nucleic acids into cells or target cells and producing cellular pharmaceuticals. The cationic lipid serves as a delivery carrier, enhancing the efficiency of nucleic acid delivery.

Career Highlights

Throughout her career, Kasumi Ito has worked with notable organizations, including Nof Corporation and Chiba University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Kasumi Ito has collaborated with esteemed colleagues such as Masamichi Tamada and Tokihiro Tanaka. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Kasumi Ito's work in the field of nucleic acid delivery represents a significant advancement in biotechnology. Her patented innovations are poised to impact the future of gene therapy and pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…